• Home
  • News
    • Pre-Meeting
    • Meeting Coverage
    • Post-Meeting
    • Poster Presenters 2024
    • Archives
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
  • Map & Photos
  • Industry
    • Industry Events
      • Featured Industry Events
      • Innovation Theaters
      • Industry-Supported Symposia
      • Lightning Talks
    • Industry Connections
  • Publications
    • Preview Edition Newspaper
    • Meeting Magazine
  • App & Planner
  • Schedule
  • Resources
    • App & Planner
    • Schedule
  • Follow Us
    • X (Twitter)
    • Facebook
    • LinkedIn
    • YouTube
  • Subscribe
Meeting Home

The official news source of ACR Convergence 2024

Watch On Demand
  • Plenary I highlights interplay between COVID-19 and autoimmune dysfunction

    Plenary I highlights interplay between COVID-19 and autoimmune dysfunction

    November 20, 2020

    Plenary Session I focused on growing links between SARS-CoV-2 infection and autoimmune events that are more often seen in rheumatologic diseases.

  • Plenary II: DOACs could be the better choice than warfarin for OA patients

    Plenary II: DOACs could be the better choice than warfarin for OA patients

    November 20, 2020

    A retrospective analysis of knee and hip replacements in patients with atrial fibrillation on anticoagulation therapy was one of the presentations during the Plenary II session during ACR Convergence 2020.

  • Mavrilimumab reduces flare and increases sustained remission in giant cell arteritis, late-breaking abstract reports

    Mavrilimumab reduces flare and increases sustained remission in giant cell arteritis, late-breaking abstract reports

    November 20, 2020

    The ACR Convergence 2020 Late-Breaking Abstracts session featured six presentations on cutting-edge science.

  • Plenary III: Data shows belimumab improves SLE control, renal outcomes, steroid use

    Plenary III: Data shows belimumab improves SLE control, renal outcomes, steroid use

    November 20, 2020

    Results from the BLISS-LN trial was one of the highlights from the Plenary III session.

  • Panelists review draft updated ACR guideline for RA management

    Panelists review draft updated ACR guideline for RA management

    November 20, 2020

    A new ACR guideline for the management of rheumatoid arthritis (RA) has been drafted and is expected to be approved later this year and published by early spring 2021.

  • Session explores COVID-19 impact on rheumatic disease populations

    Session explores COVID-19 impact on rheumatic disease populations

    November 20, 2020

    Members of the Global Rheumatology Alliance (GRA) COVID-19 Steering Committee presented data from the COVID-19 GRA Registry on the impact of the pandemic on the rheumatology community.

  • New ACR leadership confirmed at 2020 Business Meeting

    New ACR leadership confirmed at 2020 Business Meeting

    November 20, 2020

    David Karp, MD, PhD, became the 84th ACR President. Additionally, Kenneth G. Saag, MD, MSc, became ACR President-Elect, and Deborah Dyett Desir, MD, was confirmed by the membership as the new ACR Secretary.

Upcoming Featured Industry Events

View All

View Archives

  • Select Year
    • 2017
    • 2018
    • 2019
    • 2020
    • 2021
    • 2022
    • 2023

Popular Articles

  • Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease


  • ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists


  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases


  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice


  • Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology



@2024 American College of Rheumatology. All Rights Reserved. Powered by TriStar Event Media, LLC

Privacy Policy